Therefore, we tested the diagnostic ability of CTGF in the ACPA-negative population, and found that serum CTGF was able to identify more patients with RA, with sensitivity and specificity of 76% and 91%, respectively. Here, CCN2 is linked to rheumatoid arthritis.